Advances in motor neurone disease

Journal of the Royal Society of Medicine

Volumn 107, Issue 1, 2014, Pages 14-21

  Bäumer, Dirk ^a   Talbot, Kevin ^a   Turner, Martin R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

amyotrophic lateral sclerosis; anterior horn cell; autophagy; frontotemporal dementia; neurodegeneration; protein aggregation; RNA; TDP 43

Indexed keywords

BIOLOGICAL MARKER; RILUZOLE; RNA; RNA BINDING PROTEIN; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANTERIOR HORN CELL; ANTERIOR HORN CELL DISEASE; AUTOPHAGY; CLINICAL FEATURE; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; DISEASE CLASSIFICATION; DISEASE COURSE; ELECTROMYOGRAM; FRONTOTEMPORAL DEMENTIA; GASTROSTOMY; GENE EXPRESSION; GENE MUTATION; HUMAN; MOTOR NEURON DISEASE; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; NONINVASIVE VENTILATION; OCCUPATIONAL THERAPY; PALLIATIVE THERAPY; PATHOGENESIS; PHYSIOTHERAPY; PROTEIN DEGRADATION; QUALITY OF LIFE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPEECH THERAPY; TDP 43 PROTEINOPATHY;

EID: 84891839105     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/0141076813511451     Document Type: Review

References (32)

1. Kiernan MC,Vucic S,Cheah BC, et al.Amyotrophic lateral sclerosis.Lancet. 2011;377:942-55.
2. Phukan J,Elamin M,Bede P, et al.The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study.J Neurol Neurosurg Psychiatry. 2012;83:102-8.
3. Turner MR,Talbot K.Mimics and chameleons in motor neurone disease.Pract Neurol. 2013;13:153-64.
4. Brooks BR,Miller RG,Swash M,Munsat TL.El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
5. de Carvalho M,Dengler R,Eisen A, et al.Electrodiagnostic criteria for diagnosis of ALS.Clin Neurophysiol. 2008;119:497-503.
6. Costa J,Swash M,de Carvalho M.Awaji criteria for the diagnosis of amyotrophic lateral sclerosis:a systematic review.Arch Neurol. 2012;69:1410-6.
7. Roche JC,Rojas-Garcia R,Scott KM, et al.A proposed staging system for amyotrophic lateral sclerosis.Brain. 2012;135:847-52.
8. Beghi E,Logroscino G,Chio A, et al.The epidemiology of ALS and the role of population-based registries.Biochim Biophys Acta. 2006;1762:1150-7.
9. Alonso A,Logroscino G,Jick SS,Hernan MA.Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study.Eur J Neurol. 2009;16:745-51.
10. Baumer D,Hilton D,Paine SM, et al.Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations.Neurology. 2010;75:611-8.
11. Turner MR.Increased premorbid physical activity and amyotrophic lateral sclerosis: born to run rather than run to death, or a seductive myth?.J Neurol Neurosurg Psychiatry. 2013;84:947-947.
12. DeJesus-Hernandez M,Mackenzie IR,Boeve BF, et al.Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.Neuron. 2011;72:245-56.
13. van Blitterswijk M,DeJesus-Hernandez M,Rademakers R.How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?.Curr Opin Neurol. 2012;25:689-700.
14. Andersen PM,Al-Chalabi A.Clinical genetics of amyotrophic lateral sclerosis: what do we really know?.Nat Rev Neurol. 2011;7:603-15.
15. Majounie E,Renton AE,Mok K, et al.Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.Lancet Neurol. 2012;11:323-30.
16. Neumann M,Sampathu DM,Kwong LK, et al.Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.Science. 2006;314:130-3.
17. Mori K,Weng SM,Arzberger T, et al.The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.Science. 2013;339:1335-8.
18. Turner MR,Bowser R,Bruijn L, et al.Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:19-32.
19. Bäumer D,Ansorge O,Almeida M,Talbot K.The role of RNA processing in the pathogenesis of motor neuron degeneration.Expert Rev Mol Med. 2010;12:e21-e21.
20. Polymenidou M,Lagier-Tourenne C,Hutt KR, et al.Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43.Nat Neurosci. 2011;14:459-68.
21. Turner MR,Goldacre R,Ramagopalan S,Talbot K,Goldacre MJ.Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study.Neurology. 2013;81:1222-5.
22. Turner MR,Kiernan MC,Leigh PN,Talbot K.Biomarkers in amyotrophic lateral sclerosis.Lancet Neurol. 2009;8:94-109.
23. Vucic S,Cheah BC,Yiannikas C,Kiernan MC.Cortical excitability distinguishes ALS from mimic disorders.Clin Neurophysiol. 2011;122:1860-6.
24. Turner MR,Agosta F,Bede P,Govind V,Lule D,Verstraete E.Neuroimaging in amyotrophic lateral sclerosis.Biomark Med. 2012;6:319-37.
25. Hardiman O,van den Berg LH,Kiernan MC.Clinical diagnosis and management of amyotrophic lateral sclerosis.Nat Rev Neurol. 2011;7:639-49.
26. Eisen A,Turner MR.Does variation in neurodegenerative disease susceptibility and phenotype reflect cerebral differences at the network level?.Amyotroph Lateral Scler Frontotemporal Degener. 2013;:.
27. Polymenidou M,Cleveland DW.The seeds of neurodegeneration: prion-like spreading in ALS.Cell. 2011;147:498-508.
28. Ravits JM,La Spada AR.ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.Neurology. 2009;73:805-11.
29. Brockington A,Ning K,Heath PR, et al.Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity.Acta Neuropathol. 2013;125:95-109.
30. Bilican B,Serio A,Barmada SJ, et al.Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability.Proc Natl Acad Sci USA. 2012;109:5803-8.
31. Turner MR,Kiernan MC.Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?.Amyotroph Lateral Scler. 2012;13:245-50.
32. Benatar M,Wuu J.Presymptomatic studies in ALS: Rationale, challenges, and approach.Neurology. 2012;79:1732-9.